相关实验视频
Updated: Jul 15, 2025

11:27
Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
8.8K
缺氧激活SREBP2通过骨髓衍生的单细胞的戈尔基分解来激活SREBP2,以增强瘤生长
Ryuichi Nakahara1,2, Sho Aki1,2, Maki Sugaya1
1Division of Nutriomics and Oncology, RCAST, The University of Tokyo, Tokyo, Japan.
The EMBO journal
|October 2, 2023
概括
缺氧会在不成熟的骨髓细胞中触发戈尔吉-ER融合,激活SREBP2和胆固醇合成. 这一过程通过促进亲瘤原生免疫和血管生成来促进瘤生长.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 代谢调节 代谢调节 代谢调节
背景情况:
- 骨髓衍生细胞 (BMDCs) 透到瘤中,并分化为原瘤巨细胞.
- SREBP2激活对于这种差异化至关重要,但其在缺氧下的机制尚不清楚.
- 瘤缺氧形成了一个独特的微环境,影响细胞过程.
研究的目的:
- 阐明在低氧状态下BMDC中SREBP2激活的机制.
- 调查戈尔吉-ER融合在SREBP2激活中的作用.
- 确定SREBP2介导的胆固醇生物合成对瘤进展的影响.
主要方法:
- 使用的单细胞髓细胞和骨髓衍生细胞.
- 研究了低氧诱导的戈尔吉分解和戈尔吉-ER融合.
- 进行了单细胞RNA-seq分析.
- 评估了SREBP2激活和胆固醇生物合成.
- 抑制胆固醇生物合成以评估瘤生长.
主要成果:
- 缺氧诱导了单细胞髓状细胞中的戈尔基分解和戈尔基-ER融合.
- 这种融合导致SCAP独立的核转移和在不成熟的BMDC中激活SREBP2.
- 在低氧状态下,SREBP2介导的胆固醇生物合成在造血干细胞和单细胞中被上调.
- 抑制胆固醇生物合成抑制了瘤生长,原瘤免疫和血管生成.
结论:
- 戈尔吉-ER融合是SREBP2激活在低氧条件下的特定BMDC系的新机制.
- 在BMDC中,SREBP2驱动的胆固醇生物合成有助于瘤的进展.
- 准这种代谢途径为癌症治疗提供了一个潜在的策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Erythropoiesis
4.3K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.3K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K

